Literature DB >> 28535015

The circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinoma.

Xiaoli Su1, Dan Chen1, Kai Yang1, Qin Zhao1, Dan Zhao1, Xiaoqiang Lv1, Yiran Ao1.   

Abstract

Low expression of the clock gene PER2 is closely related to carcinogenesis and the development of cancer; however, the mechanism of the low expression of PER2 that led to cell malignant transformation remains unclear. This study used RNA interference (RNAi) technology to silence PER2 in SCC15 human oral squamous cell carcinoma (OSCC) cells. Then it was found that the ability of cancer cell proliferation, migration, and invasion were markedly increased (P<0.05), and the ability of cancer cell apoptosis and the number of cells in G1/G0 phase were markedly reduced (P<0.05) after PER2 knockdown. PER2 knockdown increased the expression of Ki-67, MDM2, c-Myc, Bcl-2, MMP2, and VEGF mRNA (P<0.05), and decreased the expression of p53, Bax, and TIMP-2 mRNA (P<0.05). The in vivo experiments also proved that the tumorigenicity of SCC15 cells was significantly enhanced after PER2 silence (P<0.05). Overall, these results show that PER2 through the regulation of the numerous important downstream tumor-related genes, plays a major role in tumor suppression, and it may be a novel molecular target for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28535015     DOI: 10.3892/or.2017.5653

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study.

Authors:  Jenny L Smith; Rhonda E Ries; Tiffany Hylkema; Todd A Alonzo; Robert B Gerbing; Marianne T Santaguida; Lisa Eidenschink Brodersen; Laura Pardo; Carrie L Cummings; Keith R Loeb; Quy Le; Suzan Imren; Amanda R Leonti; Alan S Gamis; Richard Aplenc; E Anders Kolb; Jason E Farrar; Timothy J Triche; Cu Nguyen; Daoud Meerzaman; Michael R Loken; Vivian G Oehler; Hamid Bolouri; Soheil Meshinchi
Journal:  Clin Cancer Res       Date:  2019-11-12       Impact factor: 12.531

Review 2.  The role of circadian clock genes in tumors.

Authors:  Han-Xue Li
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

3.  Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo.

Authors:  Xuefeng Zhao; Juan Fan; Peng Wu; Chengming Wei; Qiongying Chen; Zhi Ming; Jun Yan; Linglin Yang
Journal:  Int J Nanomedicine       Date:  2019-02-19

Review 4.  Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Authors:  Choudhary Harsha; Kishore Banik; Hui Li Ang; Sosmitha Girisa; Rajesh Vikkurthi; Dey Parama; Varsha Rana; Bano Shabnam; Elina Khatoon; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

Review 5.  The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics.

Authors:  Elizabeth Cash; Sandra Sephton; Cassandra Woolley; Attia M Elbehi; Anu R I; Bene Ekine-Afolabi; Victor C Kok
Journal:  J Exp Clin Cancer Res       Date:  2021-04-01

6.  A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes.

Authors:  Müge Yalçin; Deeksha Malhan; Alireza Basti; Ana Rita Peralta; Joaquim J Ferreira; Angela Relógio
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 7.  Daily Lifestyle and Cutaneous Malignancies.

Authors:  Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 8.  The Role of Dynamic m6 A RNA Methylation in Photobiology.

Authors:  Myles Robinson; Palak Shah; Yan-Hong Cui; Yu-Ying He
Journal:  Photochem Photobiol       Date:  2018-05-24       Impact factor: 3.521

9.  Clinicopathologic Features and Treatment Outcomes in Patients with Stage I, High-Risk Histology or High-Grade Endometrial Cancer after Primary Staging Surgery: A Taiwanese Gynecologic Oncology Group Study.

Authors:  Ming-Shyen Yen; Tze-Ho Chen; Yu-Min Ke; Keng-Fu Hsu; Jen-Ruei Chen; Mu-Hsien Yu; Hung-Chun Fu; Chia-Yen Huang; An-Jen Chiang; Chao-Yu Chen; Sheng-Mou Hsiao; Yuen-Yee Kan; Fu-Shing Liu
Journal:  J Clin Med       Date:  2018-09-04       Impact factor: 4.241

Review 10.  Non-transcriptional processes in circadian rhythm generation.

Authors:  David Cs Wong; John S O'Neill
Journal:  Curr Opin Physiol       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.